YTHDF2 is a Potential Biomarker and Associated with Immune Infiltration in Kidney Renal Clear Cell Carcinoma

YTHDF2 is a Potential Biomarker and Associated with Immune Infiltration in Kidney Renal Clear Cell Carcinoma

Clear cell renal cell carcinoma (ccRCC or KIRC) has a high mortality rate globally. It is necessary to identify biomarkers and investigate the mechanisms those biomarkers are associated with, to improve the prognosis of patients with KIRC. N6-Methyladenosine (m6A) affects the fate of modified RNA mo...

Full description

Bibliographic Details
Main Authors:	Ganglin Su, Tianshu Liu, Xiaohong Han, Hao Sun, Wenan Che, Kun Hu, Junwen Xiao, Yanfeng Li, Yuchen Liu, Wujiao Li, Hongbing Mei
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-08-01
Series:	Frontiers in Pharmacology
Subjects:	YTHDF2 KIRC biomarker prognosis immune infiltrates N6-methyladenosine (m6A) RNA methylation
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2021.709548/full

Similar Items

FBW7 suppresses ovarian cancer development by targeting the N6-methyladenosine binding protein YTHDF2
by: Fei Xu, et al.
Published: (2021-03-01)

YTHDF1 Facilitates the Progression of Hepatocellular Carcinoma by Promoting FZD5 mRNA Translation in an m6A-Dependent Manner
by: Xiangxiang Liu, et al.
Published: (2020-12-01)

YTHDF1 Aggravates the Progression of Cervical Cancer Through m6A-Mediated Up-Regulation of RANBP2
by: Haocheng Wang, et al.
Published: (2021-03-01)

Ythdf2-mediated m6A mRNA clearance modulates neural development in mice
by: Miaomiao Li, et al.
Published: (2018-05-01)

The m6A Reader YTHDF1 Facilitates the Tumorigenesis and Metastasis of Gastric Cancer via USP14 Translation in an m6A-Dependent Manner
by: Xiao-Yu Chen, et al.
Published: (2021-03-01)

YTHDF2 Regulates Maternal Transcriptome Degradation and Embryo Development in Goat
by: Mingtian Deng, et al.
Published: (2020-09-01)

Research Progress on Relation Between YTHDF1 and Tumors
by: XIAO Shiwei, et al.
Published: (2020-09-01)

Prognostic Value of YTHDF2 in Clear Cell Renal Cell Carcinoma
by: Zhongyi Mu, et al.
Published: (2020-09-01)

N6-methyladenosine of HIV-1 RNA regulates viral infection and HIV-1 Gag protein expression
by: Nagaraja Tirumuru, et al.
Published: (2016-07-01)

YTHDF1 and YTHDF2 are associated with better patient survival and an inflamed tumor-immune microenvironment in non–small-cell lung cancer
by: Kazuo Tsuchiya, et al.
Published: (2021-01-01)

METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer
by: Xiaoxiang Chen, et al.
Published: (2020-06-01)

YTHDF2 reduction fuels inflammation and vascular abnormalization in hepatocellular carcinoma
by: Jiajie Hou, et al.
Published: (2019-11-01)

YTHDF2 alleviates cardiac hypertrophy via regulating Myh7 mRNA decoy
by: Hongfei Xu, et al.
Published: (2021-07-01)

Potential Impact of ALKBH5 and YTHDF1 on Tumor Immunity in Colon Adenocarcinoma
by: Guanyu Yan, et al.
Published: (2021-05-01)

YTHDF2, a protein repressed by miR-145, regulates proliferation, apoptosis, and migration in ovarian cancer cells
by: Jie Li, et al.
Published: (2020-09-01)

YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer
by: Jiangfeng Li, et al.
Published: (2020-10-01)

Long noncoding RNA GAS5 inhibits progression of colorectal cancer by interacting with and triggering YAP phosphorylation and degradation and is negatively regulated by the m6A reader YTHDF3
by: Wen Ni, et al.
Published: (2019-10-01)

Emerging Roles of N6-Methyladenosine on HIV-1 RNA Metabolism and Viral Replication
by: Sebastián Riquelme-Barrios, et al.
Published: (2018-03-01)

YTHDF1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy
by: Jian Hu, et al.
Published: (2021-05-01)

YTHDF2 Inhibits Gastric Cancer Cell Growth by Regulating FOXC2 Signaling Pathway
by: Xudong Shen, et al.
Published: (2021-01-01)

PBRM1 Cooperates with YTHDF2 to Control HIF-1α Protein Translation
by: Alena Shmakova, et al.
Published: (2021-06-01)

The biological function of m6A reader YTHDF2 and its role in human disease
by: Jin-yan Wang, et al.
Published: (2021-02-01)

Increased expression of YTHDF1 and HNRNPA2B1 as potent biomarkers for melanoma: a systematic analysis
by: Tengda Li, et al.
Published: (2020-06-01)

Histone lactylation drives oncogenesis by facilitating m6A reader protein YTHDF2 expression in ocular melanoma
by: Jie Yu, et al.
Published: (2021-03-01)

The N6-Methyladenosine (m6A) Methylation Gene YTHDF1 Reveals a Potential Diagnostic Role for Gastric Cancer
by: Liu T, et al.
Published: (2020-11-01)

METTL3 Facilitates Oral Squamous Cell Carcinoma Tumorigenesis by Enhancing c-Myc Stability via YTHDF1-Mediated m6A Modification
by: Wei Zhao, et al.
Published: (2020-06-01)

Systematic Analyses of the Role of the Reader Protein of N6-Methyladenosine RNA Methylation, YTH Domain Family 2, in Liver Hepatocellular Carcinoma
by: Xiang-yang Shao, et al.
Published: (2020-12-01)

Overexpressing PTTG family genes predict poor prognosis in kidney renal clear cell carcinoma
by: Yonghui Gui, et al.
Published: (2021-04-01)

Identification and Validation of the N6-Methyladenosine RNA Methylation Regulator YTHDF1 as a Novel Prognostic Marker and Potential Target for Hepatocellular Carcinoma
by: Saiyan Bian, et al.
Published: (2020-12-01)

m6A RNA modification and its writer/reader VIRMA/YTHDF3 in testicular germ cell tumors: a role in seminoma phenotype maintenance
by: João Lobo, et al.
Published: (2019-03-01)

Comprehensive analyses of m6A regulators and interactive coding and non-coding RNAs across 32 cancer types
by: Sipeng Shen, et al.
Published: (2021-04-01)

Genome-Wide Maps of m6A circRNAs Identify Widespread and Cell-Type-Specific Methylation Patterns that Are Distinct from mRNAs
by: Chan Zhou, et al.
Published: (2017-08-01)

MicroRNA related prognosis biomarkers from high throughput sequencing data of kidney renal clear cell carcinoma
by: Minjiang Huang, et al.
Published: (2021-03-01)

YTHDF2 facilitates UBXN1 mRNA decay by recognizing METTL3-mediated m6A modification to activate NF-κB and promote the malignant progression of glioma
by: Rui-Chao Chai, et al.
Published: (2021-07-01)

m6A RNA Methylation Regulator YTHDF1 Correlated With Immune Microenvironment Predicts Clinical Outcomes and Therapeutic Efficacy in Breast Cancer
by: Ying Hu, et al.
Published: (2021-08-01)

Recent Advances in Identification of RNA Modifications
by: Wei Chen, et al.
Published: (2016-12-01)

YTHDF2 suppresses the plasmablast genetic program and promotes germinal center formation
by: Grenov, A., et al.
Published: (2022)

Dysregulated m6A-Related Regulators Are Associated With Tumor Metastasis and Poor Prognosis in Osteosarcoma
by: Jianhao Li, et al.
Published: (2020-06-01)

YTHDF1 Promotes Cyclin B1 Translation through m<sup>6</sup>A Modulation and Contributes to the Poor Prognosis of Lung Adenocarcinoma with KRAS/TP53 Co-Mutation
by: Xiaoying Lou, et al.
Published: (2021-07-01)

YTHDF1 promotes hepatocellular carcinoma progression via activating PI3K/AKT/mTOR signaling pathway and inducing epithelial-mesenchymal transition
by: Xiangyuan Luo, et al.
Published: (2021-06-01)